Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Ureteral Injury
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

To determine the safety profile of sodium fluorescein in women undergoing cystoscopy during gynecologic surgery. To determine if either oral phenazopyridine or sodium fluorescein result in shorter cystoscopy times.

Provided treatments

  • Drug: sodium fluorescein
  • Drug: phenazopyridine
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02757417. The sponsor of the trial is University Hospitals Cleveland Medical Center and it is looking for 88 volunteers for the current phase.
Official trial title:
A Randomized Trial Comparing Intaoperative Intravenous Sodium Fluorescein to Pre-Operative Oral Phenazopyridine For Evaluation of Ureteral Patency